- Discussion: "Correlations for Prediction of Pressure Gradient of Liquid-Liquid Flow Through a Circular Horizontal Pipe" [Dasari, A., Desamala, A. B., Ghosh, U. K., Dasmahapatra, A. K., and Mandal, T. K., 2014, ASME J. Fluids Eng., 136(7), p. 071302]
- Discussion of %26quot;Carbon benefits of wolfberry plantation on secondary saline land in Jingtai oasis, Gansu - A case study on application of the CBP model%26quot; by Yaolin Wang, Chuanyan Zhao, Quanlin Ma, Yingke Li, Hujia Jing, Tao Sun, Eleanor Milne, Mark Easter, Keith Paustian, Hoi Wen Au Yong, John McDonagh (2015) [Journal of Environmental Management 157, 303-3101
- Discussion: On 'Negative apparent resistivity in dipole-dipole electrical surveys' (Jung, HK, Min, DJ, Lee, HS, Oh, SH, and Chung, H., Exploration Geophysics, 40, 33-40) Reply
- Discussion: "Comparison of Statistical Methods for Assessing Spatial Correlations Between Maps of Different Arterial Properties" (Rowland, E. M., Mohamied, Y., Chooi, K. Y., Bailey, E. L., and Weinberg, P. D., 2015, ASME J. Biomech. Eng., 137(10), p. 101003): An Alternative Approach Using Segmentation Based on Local Hemodynamics
- Discovery of (10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro- 2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]-benzoxadiazacyclotetradecine-3-c arbonitrile (PF-06463922), a Macrocyclic Inhibitor of Anaplastic Lymphoma Kinase (ALK) and c-ros Oncogene 1 (ROS1) with Preclinical Brain Exposure and Broad-Spectrum Potency against ALK-Resistant Mutations
- Discovery of the Macrocycle 11-(2-Pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3. 1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a Potent Janus Kinase 2/Fms-Like Tyrosine Kinase-3 (JAK2/FLT3) Inhibitor for the Treatment of Myelofibrosis and Lymphoma
- Discovery of Kinase Spectrum Selective Macrocycle (16E)-14-Methyl-20-oxa-5,7,14,26-tetraazatetracyclo[19.3.1.1(2,6).1(8,12 )]heptacosa-1(25),2(26),3,5,8(27),9,11,16,21,23-decaene (SB1317/TG02), a Potent Inhibitor of Cyclin Dependent Kinases (CDKs), Janus Kinase 2 (JAK2), and Fms-like Tyrosine Kinase-3 (FLT3) for the Treatment of Cancer
- Discovery of the Macrocycle (9E)-15-(2-(Pyrrolidin-1-yl)ethoxy)-7,12,25-trioxa-19,21,24-triaza-tetra cyclo[18.3.1.1(2,5).1(14,18)]hexacosa-1(24),2,-4,9,14(26),15,17,20,22-no naene (SB1578), a Potent Inhibitor of Janus Kinase 2/Fms-LikeTyrosine Kinase-3 (JAK2/FLT3) for the Treatment of Rheumatoid Arthritis
- Discussion to "Evaluation of landslide triggering mechanisms in model fill slopes" by W.A Take M.D. Bolton, P.C.P. Wong, and F.J. Yeung [Landslides 1(3): 173-184, October 2004] and "A fluidized landslide on a natural slope by artificial rainfall" by H. Ochiai, Y. Okada, G. Furuya, Y. Okura, T. Matsui, T. Sammori, T. Terajima, and K. Sassa [Landslides 1(3): 211-219 (October 2004)]